Newsroom Stories

Using a variety of microscopic analysis techniques not available when the Apollo astronauts first returned samples from the moon, physicist Ryan Ogliore in Arts & Sciences helped unlock the secrets of tiny lunar beads.

Environmental engineers at WashU have developed hydrogels to transform wastewater nutrients into useful feedstocks and fertilizers.

Beverly R. Wendland, provost and executive vice chancellor for academic affairs, will complete her provost appointment after a successful five-year term in the role. Her transition is effective July 31, according to Chancellor Andrew D. Martin.

Jennifer Phillips-Cremins, a pioneer in understanding 3D genome structure and its impact on the brain, will join WashU Medicine as BJC Investigator.

At the WashU Board of Trustees meeting in May, numerous faculty members were appointed, promoted or granted tenure, with most taking effect July 1.

The Rev. Callista Isabelle, the inaugural director for religious, spiritual and ethical life at WashU, received this year’s Gloria W. White Distinguished Service Award, which is given to a staff member who exceeds their daily work duties to make a positive impact on employees and the university at large.

A study led by physicist Shankar Mukherji in Arts & Sciences uses a new technique to simultaneously visualize how six major organelles within a cell change as the cell grows. The work has implications for how cells regulate metabolism and growth, which is important in both health and disease.

As U.S. public health funding falters, WashU experts warn that vital global data systems protecting women and children from violence are in danger of disappearing.

As the Oklahoma Legislature clears the way for autonomous practice by nurse practitioners, it’s time for a broader conversation regarding the scope and duration of training and certification needed to independently provide care to patients of all types, says Patrick Aguilar, MD, a business of health expert at WashU Olin Business School.

An international clinical trial led by WashU Medicine researchers shows an innovative CAR-T cell immunotherapy is promising against aggressive T cell cancers and has manageable side effects.